Detailed Information on Publication Record
2019
Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress
JELÍNKOVÁ, Šárka, Aneta KOHUTOVÁ, Petr FOJTÍK, Miriama KRUTÁ, Aleksandra VILOTIĆ et. al.Basic information
Original name
Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress
Authors
JELÍNKOVÁ, Šárka (203 Czech Republic, belonging to the institution), Aneta KOHUTOVÁ (703 Slovakia, belonging to the institution), Petr FOJTÍK (203 Czech Republic, belonging to the institution), Miriama KRUTÁ (703 Slovakia, belonging to the institution), Aleksandra VILOTIĆ (688 Serbia, belonging to the institution), Martin PEŠL (203 Czech Republic, belonging to the institution), Jan VRBSKÝ (203 Czech Republic), Renata GAILLYOVÁ (203 Czech Republic, belonging to the institution), Iveta VALÁŠKOVÁ (203 Czech Republic, belonging to the institution), Ivan FRÁK (703 Slovakia, belonging to the institution), Giancarlo FORTE (380 Italy), Petr DVOŘÁK (203 Czech Republic, belonging to the institution), Albano MELI (250 France, belonging to the institution), Vladimír ROTREKL (203 Czech Republic, guarantor, belonging to the institution), Lenka MARKOVÁ (203 Czech Republic, belonging to the institution), Tereza JURÁKOVÁ (203 Czech Republic, belonging to the institution) and Alain LACAMPAGNE (250 France)
Edition
Cells, Basel, MDPI, 2019, 2073-4409
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10601 Cell biology
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.366
RIV identification code
RIV/00216224:14110/19:00107273
Organization unit
Faculty of Medicine
UT WoS
000459742400053
Keywords in English
DMD; dystrophin; pluripotent stem cells; genome stability; ROS; NO synthases
Tags
International impact, Reviewed
Změněno: 29/4/2020 07:43, Mgr. Tereza Miškechová
Abstract
V originále
Recent data on Duchenne muscular dystrophy (DMD) show myocyte progenitor’s involvement in the disease pathology often leading to the DMD patient’s death. The molecular mechanism underlying stem cell impairment in DMD has not been described. We created dystrophin-deficient human pluripotent stem cell (hPSC) lines by reprogramming cells from two DMD patients, and also by introducing dystrophin mutation into human embryonic stem cells via CRISPR/Cas9. While dystrophin is expressed in healthy hPSC, its deficiency in DMD hPSC lines induces the release of reactive oxygen species (ROS) through dysregulated activity of all three isoforms of nitric oxide synthase (further abrev. as, NOS). NOS-induced ROS release leads to DNA damage and genomic instability in DMD hPSC. We were able to reduce both the ROS release as well as DNA damage to the level of wild-type hPSC by inhibiting NOS activity.
Links
GBP302/12/G157, research and development project |
| ||
MUNI/A/1087/2018, interní kód MU |
| ||
7AMB13FR011, research and development project |
|